A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
First-in-human report for UltiSynq CSP ICD lead ...
New research highlights postnatal regeneration limits and pathological remodeling of the cardiac conduction system after myocardial infarction, uncovering mechanisms behind clinical arrhythmogenesis ...
NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
BERLIN, Germany—Conduction-system pacing (CSP), including His-bundle and left bundle branch area pacing (LBBAP), has emerged as an alternative to biventricular pacing for patients treated with cardiac ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
BARCELONA, Spain—The European Heart Rhythm Society (EHRA) has released a new consensus statement on conduction system pacing (CSP), which includes both His-bundle and left bundle branch (LBB) pacing, ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging geography in the heart, for delivering electric signals that more closely ...
Medtronic has secured FDA approval for its OmniaSecure defibrillation lead to be used in conduction system pacing, the first device cleared for left bundle branch area placement. The small, lumenless ...
ECG aberrancy means the heartbeat does not follow the usual conduction system of the heart. Atrial fibrillation with ECG aberrancy means people have an irregular heart rhythm with abnormal conduction.